Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
PLoS One. 2013;8(2):e56481. doi: 10.1371/journal.pone.0056481. Epub 2013 Feb 15.
Cysteine-rich protein 61 (Cyr61) is a secreted matrix-associated protein that regulates a broad spectrum of biological and cellular activities. This study aimed to investigate the role of Cyr61 in progressive kidney fibrosis induced by unilateral ureteral obstruction (UUO) surgery in mice. The expression of Cyr61 transcripts and proteins in the obstructed kidneys were increased from day 1 and remained high until day 10 after surgery. Immunohistochemistry indicated that Cyr61 was expressed mainly in renal tubular epithelial cells. The upregulated Cyr61 in UUO kidneys was reduced in mice treated with pan-transforming growth factor-β (TGF-β) antibody. The role of TGF-β in tubular Cyr61 upregulation after obstructive kidney injury was further supported by experiments showing that TGF-β1 stimulated Cyr61 expression in cultured tubular epithelial cells. Notably, the upregulation of Cyr61 in UUO kidneys was followed by a marked increase in monocyte chemoattractant protein 1 (MCP-1) transcripts and macrophage infiltration, which were attenuated in mice treated with anti-Cyr61 antibodies. This proinflammatory property of Cyr61 in inducing MCP-1 expression was further confirmed in tubular epithelial cells cultured with Cyr61 protein. The anti-Cyr61 antibody in UUO mice also reduced the levels of collagen type 1-α1 transcripts, collagen fibril accumulation evaluated by picrosirius red staining, and the levels of α-smooth muscle actin (α-SMA) transcripts and proteins on day 4 after surgery; however, the antifibrotic effect was not sustained. In conclusion, the TGF-β-mediated increase in tubular Cyr61 expression involved renal inflammatory cell infiltration through MCP-1 induction during obstructive kidney injury. The Cyr61 blockade attenuated kidney fibrosis in the early phase, but the antifibrotic effect could not be sustained.
富含半胱氨酸蛋白 61(Cyr61)是一种分泌型基质相关蛋白,可调节广泛的生物和细胞活动。本研究旨在探讨 Cyr61 在单侧输尿管梗阻(UUO)手术诱导的进行性肾纤维化中的作用。阻塞肾脏中 Cyr61 转录物和蛋白的表达从第 1 天开始增加,并在手术后第 10 天仍然很高。免疫组织化学表明 Cyr61 主要在肾小管上皮细胞中表达。用泛转化生长因子-β(TGF-β)抗体治疗的小鼠中,UUO 肾脏中上调的 Cyr61 减少。实验进一步支持 TGF-β 在阻塞性肾损伤后肾小管 Cyr61 上调中的作用,表明 TGF-β1 刺激培养的肾小管上皮细胞中 Cyr61 的表达。值得注意的是,UUO 肾脏中 Cyr61 的上调伴随着单核细胞趋化蛋白 1(MCP-1)转录物和巨噬细胞浸润的显著增加,用抗 Cyr61 抗体治疗的小鼠中这种增加减少。在用 Cyr61 蛋白培养的肾小管上皮细胞中进一步证实了 Cyr61 诱导 MCP-1 表达的这种促炎特性。在 UUO 小鼠中使用抗 Cyr61 抗体也降低了手术后第 4 天胶原 1-α1 转录物、天狼星红染色评估的胶原纤维积累以及α-平滑肌肌动蛋白(α-SMA)转录物和蛋白的水平;然而,抗纤维化作用不能持续。总之,TGF-β 介导的肾小管 Cyr61 表达增加涉及在阻塞性肾损伤期间通过诱导 MCP-1 导致肾脏炎症细胞浸润。Cyr61 阻断在早期阶段减轻了肾脏纤维化,但抗纤维化作用不能持续。